A carregar...
Targeting CDK9 for Anti-Cancer Therapeutics
SIMPLE SUMMARY: CDK9, in combination with Cyclin T1, is one of the major regulators of RNA Polymerase II mediated productive transcription of critical genes in any cell. The activity of CDK9 is significantly up-regulated in a wide variety of cancer entities, to aid in the overexpression of genes res...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8124690/ https://ncbi.nlm.nih.gov/pubmed/34062779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13092181 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|